| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |